Akso Health Group

Annual Trend FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 TTM
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net loss from continuing operations ($4.3m) ($4.1m) ($13.1m) ($9.1m) ($135.5m)
Net Income From Continuing Operations ($13.1m) ($9.1m) ($135.5m) ($18.7m) ($18.7m)
Net Income (Loss) Attributable to Parent $65.5m
$5.5m -91.55%
($71.2m) -1386.89%
($34.8m) +51.08%
($16.9m) +51.61%
($1.4m) +91.93%
($9.5m) -595.54%
($135.0m) -1327.01%
($18.7m) +86.17%
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest $65.5m $5.5m ($71.2m) ($16.8m) ($1.2m) ($9.5m) ($135.5m)
Net Income (Loss) Attributable to Noncontrolling Interest $29k $1k $112k ($58k) ($492k)
Depreciation, Depletion and Amortization $92k $174k $407k $581k $15k $18k $0 $0 $2.1m $2.4m
Amortization of Intangible Assets $2.1m
Depreciation Amortization Depletion $0 $0 $2.1m $2.4m $2.4m
Deferred Income Tax Expense (Benefit) $416k ($3.7m) $3.6m $0 $0 ($30.8m) ($2.0m) ($2.0m)
Deferred tax (benefit) expense $136k $416k $0 $0 ($30.8m) ($2.0m)
Share-based Payment Arrangement, Noncash Expense $1.8m $6.6m $347k $55k $392k $347k
Share-based Payment Arrangement, Expense $1.8m $6.6m $347k $55k $392k $347k
Goodwill and Intangible Asset Impairment $162.4m
Goodwill, Impairment Loss $41.4m $16.7m
Impairment of Intangible Assets (Excluding Goodwill) $121.1m
Asset Impairment Charge $0 $0 $162.5m $16.7m $16.7m
Nonoperating Income (Expense) $34k
Other Nonoperating Income (Expense) $661k $2.3m $1.6m ($165k) ($781k) $1.2m ($454k)
Changes in operating assets and liabilities:
Change In Working Capital ($1.2m) $2.1m $3.0m ($11.3m) ($11.3m)
Accounts receivable ($8.1m) $327k ($860k) ($435k)
Change In Receivables ($8.1m) $327k ($860k) ($435k) ($435k)
Changes In Account Receivables ($8.1m) $327k ($860k) ($435k) ($435k)
Increase (Decrease) in Inventories $7.8m ($6.1m) ($1.5m) $0
Inventories ($7.8m) $6.1m $1.5m $0
Change In Inventory $6.1m $1.5m $0 $0 $0
Accounts payable, accrued expenses and other current liabilities ($2.6m) $2.5m ($469k) ($338k) ($82k) ($104k) $713k $166k $417k $313k
Change In Accrued Expense $0 $0 $0 $527 $527
Prepayments and other assets ($2.5m) $3.1m ($2.2m) $899k ($113k) ($507k) ($95k) ($131k) ($6.4m)
Change In Other Current Liabilities $0 $0 $82k ($57k) ($57k)
Net Cash Provided by (Used in) Operating Activities $8.2m
$87.7m +971.13%
($1.7m) -101.97%
($55.9m) -3127.23%
$10.1m +118.00%
($8.6m) -185.78%
($3.3m) +62.29%
$1.4m +141.53%
$1.2m -12.88%
($12.8m) -1186.62%
($12.8m) 0.00%
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment ($5k) $154k ($175.7m) ($175.7m)
Gain (Loss) on Disposition of Property Plant Equipment ($288k) ($456k) ($5k) ($29k) ($17k) ($5k) ($154k) $29k
Payments to Acquire Businesses, Net of Cash Acquired $93.8m $0
Net Other Investing Changes $18.5m $1.5m ($12.0m) $12.2m $12.2m
Net cash (used in)provided by investing activities from continuing operations ($67.1m) $17.4m $407k ($20.0m) $18.5m ($54.7m) ($105.9m)
Net cash provided by investing activities from discontinued operations ($1.0m) ($4.6m) ($408k) $36k ($163.5m)
NET CASH (USED IN) PROVIDED BY INVESTING ACTIVITIES ($288k) ($27.6m) ($68.1m) $12.8m ($662) ($20.0m) $18.5m ($54.7m) ($105.9m)
Net Cash Provided by (Used in) Investing Activities ($27.6m) ($68.1m) $12.8m ($662) ($20.0m) $18.5m ($54.7m) ($105.9m) ($163.5m)
Cash flows from financing activities:
Issuance Of Debt $0 $0 $350k $0
Net Issuance Payments Of Debt ($27.5m) ($7.7m) $0 $350k $350k
Net Short Term Debt Issuance ($27.5m) ($7.7m) $0 $350k $350k
Repayment Of Debt ($27.5m) ($7.7m) $0 $0 $0
Short Term Debt Issuance $0 $0 $350k $350k
Short Term Debt Payments ($27.5m) ($7.7m) $0 $0 $0
Payments for Repurchase of Common Stock $1.3m $2.7m
Payments of Ordinary Dividends, Common Stock $20 $0
Common Stock Issuance $0 $139.3m $195.9m $0 $0
Issuance Of Capital Stock $0 $139.3m $195.9m $0 $0
Net cash provided by (used in) financing activities from continuing operations $51.4m
($8.2m) -115.97%
($9.1m) -10.59%
$34.8m +483.30%
($27.5m) -179.11%
$131.7m +578.50%
$195.9m +48.79%
$350k
Net cash provided by financing activities from discontinued operations ($51.4m)
$6.7m +112.94%
$37k -99.44%
$25.7m +69419.73%
$350k
Net Cash Provided by (Used in) Financing Activities $4.3m
$47.5m +1007.95%
($29k) -100.06%
($4.0m) -13397.63%
($9.0m) -127.91%
$34.8m +484.87%
($27.5m) -179.11%
$131.7m +578.50%
$195.9m +48.79%
$350k
NET INCREASE (DECREASE) IN CASH $11.4m $113.4m ($75.3m) ($46.4m) $4.2m $6.8m ($12.7m) $77.0m $90.0m
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect ($75.3m) ($46.4m) $4.2m $6.8m ($12.7m) $77.0m $90.0m $171k
CASH AND CASH EQUIVALENTS – beginning of year $19.2m $132.6m $57.4m $10.9m $15.1m $21.9m $9.2m $86.2m $176.2m
Beginning Cash Position $21.9m $9.2m $86.2m $176.2m $176.2m
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $57.4m $10.9m $21.9m $9.2m $86.2m $176.2m $171k
EFFECT OF EXCHANGE RATE CHANGE ON CASH ($777k) $5.8m ($5.4m) $609k $3.2m $608k ($437k) ($1.3m) ($1.1m)
Effect Of Exchange Rate Changes ($437k) ($1.3m) ($1.1m) ($153k) ($153k)
Additional Supplementary Disclosures
Additional Supplementary Disclosures
Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating Activities $2.4m $2.1m $677k $337k $112k
Income Taxes Paid, Net $301k $1.0m $12.2m $3.2m $10k $39k $337k $25k $3k $2k
Additional Financial Items
Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax $3.2m ($396k)
Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, Net of Tax ($6.4m) $11.8m ($4k)
Foreign Currency Transaction Gain (Loss), before Tax ($592k) ($26)
Gain (Loss) on Termination of Lease $0
General and Administrative Expense $5.8m $9.9m $26.5m $27.2m $15.0m $15.5m $8.6m $3.6m
Goodwill $10.8m $16.7m
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent ($16.9m) ($13.1m) ($9.1m) ($135.5m)
Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest ($31.6m) ($16.8m)
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest $11.8m ($400k)
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent ($3.3m) $11.8m
Income Tax Expense (Benefit) $11.0m $1.9m $4.3m $483k $131k $18k $25k ($30.8m)
Operating Expenses $31.4m $16.9m $15.5m $8.8m $166.0m
Operating Lease, Expense $2.0m $399k $467k $11k
Proceeds from Contributed Capital $124k
Proceeds from Noncontrolling Interests $4.5m
Proceeds from Stock Options Exercised $1.2m $282k $5
Revenue from Contract with Customer, Including Assessed Tax $82.6m $19.0m $6.3m $13.2m
Loss from disposal of discontinued operations ($3.2m) $396k
(Recovery of) Provision for doubtful accounts $1.1m $16.1m $8.3m $7.4m ($100k)
Operating lease liabilities $754k ($787k) $82k
Contract liabilities $301k ($65k) $194k $221k $9.9m
Taxes payable $2.2m $14.7m ($9.4m) ($2.6m) $337k ($184k) $3k ($22k) ($41k)
Cash paid for loan originations ($34.7m) ($123.5m) ($6.1m) ($20.0m) ($1.5m) ($35.5m)
Cah paid in connection with acquisition ($56.2m) ($93.8m)
Cash received from loan repayments $7.5m $72.9m $33.8m $407k $41k $20.0m $1.5m $23.5m
Repayments of loans due to related parties ($5.9m) ($27.5m) ($7.7m)
Proceeds from private placement, net of offering costs $2.0m $10.0m $139.3m $195.9m
Less: cash and cash equivalents of discontinued operations at end of period $13.6m $3.5m $1.3m $1.0m
Cash and cash equivalents of continuing operations, at end of period $19.2m $132.6m $18.4m $7.9m $85.2m $176.2m
Cash Flow From Continuing Financing Activities ($27.5m) $131.7m $195.9m $350k $350k
Cash Flow From Continuing Investing Activities $18.5m ($54.7m) ($105.9m) ($163.5m) ($163.5m)
Cash From Discontinued Financing Activities $0 $0 $0 $0 $0
Cash From Discontinued Investing Activities $0 $0 $0 $0 $0
Change In Account Payable $713k $166k $417k $313k $313k
Change In Cash Supplemental As Reported ($12.7m) $77.0m $90.0m ($176.1m)
Change In Income Tax Payable $3k ($22k) ($41k) $59k $59k
Change In Interest Payable $0 $0 $0 $527 $527
Change In Other Working Capital $194k $221k $9.9m ($5.8m) ($5.8m)
Change In Payable $716k $144k $377k $372k $313k
Change In Prepaid Assets ($95k) ($131k) ($6.4m) ($5.4m) ($5.4m)
Change In Tax Payable $3k ($22k) ($41k) $59k $59k
Changes In Cash ($12.3m) $78.3m $91.1m ($175.9m) ($175.9m)
End Cash Position $9.2m $86.2m $176.2m $171k $171k
Financing Cash Flow ($27.5m)
$131.7m +578.50%
$195.9m +48.79%
$350k -99.82%
$350k 0.00%
Free Cash Flow ($3.3m) $1.4m $1.0m ($188.5m) ($188.5m)
Investing Cash Flow $18.5m ($54.7m) ($105.9m) ($163.5m) ($163.5m)
Net Business Purchase And Sale $0 ($56.2m) ($93.8m) $0 $0
Net Intangibles Purchase And Sale $0 $0 ($175.7m) ($175.7m)
Net PPE Purchase And Sale $0 $0 ($154k) ($2k) ($2k)
Other Non Cash Items $396k ($99k) $84k
Proceeds From Stock Option Exercised $0 $0 $282k
Provisionand Write Offof Assets $8.3m $7.4m ($100k) $109k $109k
Purchase Of Business $0 ($56.2m) ($93.8m) $0 $0
Purchase Of Intangibles $0 $0 ($175.7m) ($175.7m)
Purchase Of PPE $456k $945k $315k $200k $5k $0 $0 ($154k) ($2k) ($175.7m)
Stock Based Compensation $392k $0 $0 $347k